Clinical Trial Update: Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial of nab-paclitaxel plus gemcitabine with proton therapy for locally advanced pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Locally Advanced Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING